Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?

被引:1
作者
Peter, Rajesh [1 ]
Reilly, Elizabeth
Anthony, Sony [2 ]
机构
[1] Neath Port Talbot Hosp, Dept Endocrinol & Diabet, Abertawe Bro Morgannwg Univ Hlth Board, Port Talbot SA12 7BX, Wales
[2] N Tees & Hartlepool NHS Trust, Univ Hosp Hartlepool, Hartlepool, England
关键词
RANDOMIZED CONTROLLED-TRIAL; FENOFIBRATE; PROGRESSION; MELLITUS;
D O I
10.1097/MOL.0b013e3283404ff1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:554 / 555
页数:2
相关论文
共 8 条
[1]   Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS) [J].
Ansquer, JC ;
Foucher, C ;
Rattier, S ;
Taskinen, MR ;
Steiner, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (03) :485-493
[2]   Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes. [J].
Chew, Emily Y. ;
Ambrosius, Walter T. ;
Davis, Matthew D. ;
Danis, Ronald P. ;
Gangaputra, Sapna ;
Greven, Craig M. ;
Hubbard, Larry ;
Esser, Barbara A. ;
Lovato, James F. ;
Perdue, Letitia H. ;
Goff, David C., Jr. ;
Cushman, William C. ;
Ginsberg, Henry N. ;
Elam, Marshall B. ;
Genuth, Saul ;
Gerstein, Hertzel C. ;
Schubart, Ulrich ;
Fine, Lawrence J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) :233-244
[4]   Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes - The FIELD Helsinki substudy [J].
Forsblom, Carol ;
Hiukka, Anne ;
Leinonen, Eeva S. ;
Sundvall, Jouko ;
Groop, Per-Henrik ;
Taskinen, Marja-Riitta .
DIABETES CARE, 2010, 33 (02) :215-220
[5]  
Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
[6]   Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial [J].
Keech, A ;
Simes, RJ ;
Barter, P ;
Best, J ;
Scott, R ;
Taskinen, MR ;
Forder, P ;
Pillai, A ;
Davis, T ;
Glasziou, P ;
Drury, P ;
Kesäniemi, YA ;
Sullivan, D ;
Hunt, D ;
Colman, P ;
d'Emden, M ;
Whiting, M ;
Ehnholm, C ;
Laakso, M .
LANCET, 2005, 366 (9500) :1849-1861
[7]   Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial [J].
Keech, A. C. ;
Mitchell, P. ;
Summonen, P. A. ;
O'Day, J. ;
Davis, T. M. E. ;
Moffitt, M. S. ;
Taskinen, M. R. ;
Simes, R. J. ;
Tse, D. ;
Williamson, E. ;
Merrifield, A. ;
Laatikainen, L. T. ;
d'Emden, M. C. ;
Crimet, D. C. ;
O'Connell, R. L. ;
Colman, P. G. .
LANCET, 2007, 370 (9600) :1687-1697
[8]   Fibrates, Glitazones, and Peroxisome Proliferator-Activated Receptors [J].
Lalloyer, Fanny ;
Staels, Bart .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (05) :894-899